Found 72 results
Filters: Keyword is Brain  [Clear All Filters]
2022
Cho J, Nguyen TD, Huang W, Sweeney EM, Luo X, Kovanlikaya I, Zhang S, Gillen KM, Spincemaille P, Gupta A et al..  2022.  Brain oxygen extraction fraction mapping in patients with multiple sclerosis.. J Cereb Blood Flow Metab. 42(2):338-348.
Li J, Huang W, Luo X, Wen Y, Cho J, Kovanlikaya I, Gauthier SA, Nguyen TD, Spincemaille P, Wang Y.  2022.  The central vein sign in multiple sclerosis lesions: Susceptibility relaxation optimization from a routine MRI multiecho gradient echo sequence.. J Neuroimaging. 32(1):48-56.
Marcille M, Rúa SHurtado, Tyshkov C, Jaywant A, Comunale J, Kaunzner UW, Nealon N, Perumal JS, Zexter L, Zinger N et al..  2022.  Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis.. Sci Rep. 12(1):4411.
Dimov AV, Nguyen TD, Spincemaille P, Sweeney EM, Zinger N, Kovanlikaya I, Kopell BH, Gauthier SA, Wang Y.  2022.  Global cerebrospinal fluid as a zero-reference regularization for brain quantitative susceptibility mapping.. J Neuroimaging. 32(1):141-147.
Rúa SMHurtado, Kaunzner UW, Pandya S, Sweeney E, Tozlu C, Kuceyeski A, Nguyen TD, Gauthier SA.  2022.  Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients.. Eur J Neurol. 29(1):237-246.
Zhang H, Nguyen TD, Zhang J, Marcille M, Spincemaille P, Wang Y, Gauthier SA, Sweeney EM.  2022.  QSMRim-Net: Imbalance-aware learning for identification of chronic active multiple sclerosis lesions on quantitative susceptibility maps.. Neuroimage Clin. 34:102979.
Huang W, Sweeney EM, Kaunzner UW, Wang Y, Gauthier SA, Nguyen TD.  2022.  Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination.. J Neuroimaging. 32(4):667-675.
Kim J, Nguyen TD, Zhang J, Gauthier SA, Marcille M, Zhang H, Cho J, Spincemaille P, Wang Y.  2022.  Subsecond accurate myelin water fraction reconstruction from FAST-T data with 3D UNET.. Magn Reson Med. 87(6):2979-2988.
2019
Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, P Mozley D.  2019.  18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.. J Neuroimaging. 29(1):97-103.
Spincemaille P, Liu Z, Zhang S, Kovanlikaya I, Ippoliti M, Makowski M, Watts R, de Rochefort L, Venkatraman V, Desmond P et al..  2019.  Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness.. J Neuroimaging. 29(6):689-698.
Linden JR, Flores C, Schmidt EF, Uzal FA, Michel AO, Valenzuela M, Dobrow S, Vartanian T.  2019.  Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL.. PLoS Pathog. 15(11):e1008014.
Demertzi A, Tagliazucchi E, Dehaene S, Deco G, Barttfeld P, Raimondo F, Martial C, Fernández-Espejo D, Rohaut B, Voss HU et al..  2019.  Human consciousness is supported by dynamic complex patterns of brain signal coordination.. Sci Adv. 5(2):eaat7603.
Roh DJ, Albers DJ, Magid-Bernstein J, Doyle K, Hod E, Eisenberger A, Murthy S, Witsch J, Park S, Agarwal S et al..  2019.  Low hemoglobin and hematoma expansion after intracerebral hemorrhage.. Neurology. 93(4):e372-e380.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Kang Y, Gauthier SA.  2019.  PET is necessary to make the next step forward in understanding MS pathophysiology - Commentary.. Mult Scler. 25(8):1090-1091.
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.